Reply to K. Jackson et al and W. Leppert

Comment

Janet Hardy et al. J Clin Oncol. 2013.

. 2013 Apr 1;31(10):1375-6.

doi: 10.1200/JCO.2012.47.9469.

No abstract available

Comment on

Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain.
Hardy J, Quinn S, Fazekas B, Plummer J, Eckermann S, Agar M, Spruyt O, Rowett D, Currow DC. Hardy J, et al. J Clin Oncol. 2012 Oct 10;30(29):3611-7. doi: 10.1200/JCO.2012.42.1081. Epub 2012 Sep 10. J Clin Oncol. 2012. PMID: 22965960 Clinical Trial.
Ketamine and cancer pain: the reports of my death have been greatly exaggerated.
Jackson K, Franco M, William L, Poon P, Pisasale M, Kenner D, Brumley D, Mewett G, Ashby M, Viney M, Kerr D. Jackson K, et al. J Clin Oncol. 2013 Apr 1;31(10):1373-4. doi: 10.1200/JCO.2012.47.1235. Epub 2013 Feb 19. J Clin Oncol. 2013. PMID: 23423743 No abstract available.
Ketamine in the management of cancer pain.
Leppert W. Leppert W. J Clin Oncol. 2013 Apr 1;31(10):1374. doi: 10.1200/JCO.2012.47.5939. Epub 2013 Feb 19. J Clin Oncol. 2013. PMID: 23423750 No abstract available.